Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramipril
Drug ID BADD_D01909
Description Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.
Indications and Usage For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.
Marketing Status Prescription; Discontinued
ATC Code C09AA05
DrugBank ID DB00178
KEGG ID D00421
MeSH ID D017257
PubChem ID 5362129
TTD Drug ID D01STB
NDC Product Code 50090-5947; 68001-430; 82348-101; 70518-3038; 65862-477; 68382-146; 68382-147; 62135-272; 61570-112; 65841-699; 15308-0300; 61919-157; 76282-673; 57237-223; 63187-277; 68382-144; 71205-029; 0054-0106; 51655-346; 57237-222; 68001-428; 55111-438; 71335-1057; 65862-476; 69037-0051; 65862-320; 63187-854; 76282-671; 0054-0109; 68382-375; 68382-374; 51655-347; 51655-144; 71205-080; 0054-0107; 65862-474; 65862-475; 16729-152; 45865-443; 50090-3059; 55111-440; 63187-644; 17404-1021; 45865-441; 65841-655; 68001-431; 57237-224; 57237-225; 68180-590; 61570-110; 71335-1056; 50090-1118; 60760-481; 0054-0108; 63187-073; 60760-571; 50090-5673; 68001-429; 53104-7573; 71335-0894; 63629-1254; 65841-701; 68382-377; 62135-274; 61570-120; 68382-145; 55111-439; 63187-915; 63187-816; 50090-5730; 68180-591; 50090-4597; 62135-273; 16729-155; 61570-111; 65841-657; 68554-0004; 50090-4691; 65841-658; 12854-207; 16729-153; 68382-376; 65841-702; 16729-154; 55111-441; 62135-271; 65841-656; 60760-477; 76282-672; 76282-670; 50090-3873; 61919-179; 65841-700; 70518-1200; 55111-057; 63187-503; 60760-476; 58032-0123; 55700-551; 68180-589
Synonyms Ramipril | Vesdil | Triatec | Altace | Zabien | Ramace | Tritace | Acovil | Delix | Carasel | HOE-498 | HOE 498 | HOE498
Chemical Information
Molecular Formula C23H32N2O5
CAS Registry Number 87333-19-5
SMILES CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Blood pressure decreasedAngiotensin-converting enzymeP12821T8257716395257; 16138565; 9270093; 10535720; 9726242; 10620209; 10880412; 8986921; 10999650
CoughB2 bradykinin receptorP30411T2371410904024; 12522467; 11699055; 15894833
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatic cirrhosis09.01.04.0010.000104%Not Available
Hepatic failure09.01.03.0020.000261%
Hepatic function abnormal09.01.02.0010.001399%Not Available
Hepatic necrosis09.01.07.002--
Hepatitis09.01.07.004--Not Available
Hepatitis acute09.01.07.0050.000600%Not Available
Hepatitis cholestatic09.01.01.0020.000799%Not Available
Hepatitis toxic12.03.01.016; 09.01.07.0170.000400%Not Available
Hepatocellular injury09.01.07.0080.003398%Not Available
Hepatomegaly09.01.05.0010.000600%Not Available
Hepatotoxicity09.01.07.009; 12.03.01.0080.000600%Not Available
Hernia08.01.04.0010.000400%Not Available
Herpes zoster23.09.03.002; 11.05.02.003--
Hydrocele21.12.02.003; 03.03.01.0040.000600%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.004397%
Hyperkalaemia14.05.03.0010.011992%
Hyperkeratosis23.01.01.0010.000400%
Hyperplasia08.03.04.0080.000799%Not Available
Hyperreflexia17.02.01.0020.000799%Not Available
Hypersensitivity10.01.03.0030.004997%
Hypersensitivity vasculitis24.05.02.012; 10.02.02.017; 23.06.02.005; 01.01.04.0080.001799%Not Available
Hypertension24.08.02.0010.016788%
Hypertensive crisis24.08.01.0010.007395%Not Available
Hypertensive heart disease24.08.05.002; 02.01.04.0010.000104%Not Available
Hyperventilation22.02.01.006; 19.01.02.0040.001399%Not Available
Hypoaesthesia17.02.06.0230.005796%Not Available
Hypoglycaemia14.06.03.001; 05.06.03.0010.001599%
Hypokalaemia14.05.03.0020.005396%
Hypokinesia17.01.02.0090.000600%Not Available
Hyponatraemia14.05.04.0020.006396%
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 24 Pages